Five‐Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study von Budde, K., Lehner, F., Sommerer, C., Reinke, P., Arns, W., Eisenberger, U., Wüthrich, R. P., Mühlfeld, A., Heller, K., Porstner, M., Veit, J., Paulus, E.‐M., Witzke, O.

Volltext

SP0056 Potential therapeutic use of micrornas in rheumatology von Jäck, H.-M., Porstner, M., Wittmann, J., Bösl, M.

Volltext

Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD von Faatz, H, Feltgen, N, Gutfleisch, M, Heimes-Bussmann, B, Krohne, T U, Liakopoulos, S, Liegl, R, Lommatzsch, A, Mussinghoff, P, Rehak, M, Schmitz-Valckenberg, S, Spital, G, Stanzel, B, Ziemssen, F, Hägele, B, Junkes, C, Porstner, M, Vögeler, J, Gmeiner, B, Pauleikhoff, D

Volltext

A Multi-Center, Randomized, Open-Label, Parallel Group Phase IV Trial Investigating the Outcome on Renal Function, Efficacy and Safety of CNI-Reduction or Elimination With Everolim... von Deuse, T, Bara, C, Barten, M, Hirt, S, Doesch, A, Knosalla, C, Grinninger, C, Stypmann, J, Porstner, M, Wimmer, P, Schulz, U

Volltext

An Innovative Everolimus-Based Quadruple Low Immunosuppressive Regimen Compared to Standard Triple Regimen in Lung Transplant Recipients and Its Impact on Renal Function, Safety an... von Gottlieb, J, Neurohr, C, Müller-Quernheim, J, Wirtz, H, Deuse, T, Sommerwerck, U, Knosalla, C, Witt, C, Wimmer, P, Porstner, M, Strüber, M

Volltext

Efficacy and Safety of Three Different Treatment Regimens in De Novo Renal Transplant Patients: Month 36 Follow-Up Results of HERAKLES Trial: Abstract# 718 von Zeier, M., Budde, K., Arns, W., Guba, M., Sommerer, C., Neumayer, H., Jacobi, J., Kliem, V., Huppertz, A., Porstner, M., Sieder, C., Paulus, E., Witzke, O., Lehner, F.

Volltext

Outcome On Renal Function of an Everolimus Based Therapy After Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 5 Year Data of the APOLLO Trial: Abstrac... von Arns, W., Rath, T., Sommerer, C., Reinke, P., Haller, H., Suwelack, B., Huppertz, A., Porstner, M., Baeumer, D., Paulus, E., Witzke, O., Budde, K.

Volltext

Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an... von Lehner, F., Sommerer, C., Arns, W., Reinke, P., Eisenberger, U., Wuthrich, R., Pressmar, K., Hauser, I., Porstner, M., May, C., Paulus, E., Muehlfeld, A., Suwelack, B., Wolters, H., Witzke, O., Stahl, R., Budde, K.

Volltext

Post Hoc Analysis of ZEUS and HERAKLES, Two Prospective, Open-Label, Multicenter, Randomized Trials: Onset and Progression of Diabetes in Kidney Transplant Recipients On Cyclospori... von Sommerer, C., Lehner, F., Arns, W., Reinke, P., Eisenberger, U., Heller, K., Muehlfeld, A., Hauser, I., Wolters, H., Suwelack, B., Kliem, V., Jacobi, J., Stahl, R., Porstner, M., May, C., Paulus, E., Wuethrich, R., Witzke, O., Guba, M., Neumayer, H., Zeier, M., Budde, K.

Volltext

Prospektive nichtinterventionelle BLUE SKY-Studie zur Beurteilung der Wirksamkeit von Brolucizumab bei unbehandelten und vorbehandelten Patienten mit neovaskulärer AMD von Faatz, H., Feltgen, N., Gutfleisch, M., Heimes-Bussmann, B., Krohne, T. U., Liakopoulos, S., Liegl, R., Lommatzsch, A., Mussinghoff, P., Rehak, M., Schmitz-Valckenberg, S., Spital, G., Stanzel, B., Ziemssen, F., Hägele, B., Junkes, C., Porstner, M., Vögeler, J., Gmeiner, B., Pauleikhoff, D.

Volltext